NCT07009886 Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy
| NCT ID | NCT07009886 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Advanced Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 155 participants |
| Start Date | 2025-07-10 |
| Primary Completion | 2028-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 155 participants in total. It began in 2025-07-10 with a primary completion date of 2028-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To develop an educational patient decision aid for advanced cancer patients to prepare them to have conversations with their clinicians about treatment options (Treatments in Advanced cancer - Decision Aid, TA-DA).
Eligibility Criteria
Inclusion Criteria: 1. Clinicians (Part I/II/III): MD Anderson medical oncologists and APPs who provide care to patients with advanced cancer 2. Patients (Part I/II/III): Age 18 or over * Diagnosis of advanced cancer (i.e., metastatic, relapsed, and/or incurable disease as defined by the treating oncologist) who has received at least 2 lines of palliative systemic therapy\* * Patient-rated ECOG performance status of 1-3 for Part I/II and 2-3 for Part III * Able to make treatment decisions based on the clinical judgement of the oncology team * English speaking * patient has started, is receiving, and/or has completed second-line palliative systemic therapy or beyond 3. Caregivers (Part I/II/III): * Age 18 or older * Currently a primary caregiver to a patient who satisfies the patient eligibility criteria listed above * For the study purposes, a primary caregiver is defined as: * someone who provides physical, emotional, decisional and/or logistical assistance to the patient regularly (e.g. daily, weekly); * can be a family member, friend, or other individual in a close relationship with the patient; * must be identified by the patient and self-identify as the primary person providing caregiving support to the patient * Able to provide informed consent and participate in the study * English speaking Exclusion Criteria: Any patient who meets any of the following criteria will be excluded from participation in this study: * (Part I/II/III): Diagnosis of cognitive impairment or dementia requiring a surrogate decision maker as determined by the clinical team * (Part III only): Participants in Part I and II
Contact & Investigator
David Hui, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT07009886 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Advanced Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07009886 currently recruiting?
Yes, NCT07009886 is actively recruiting participants. Contact the research team at dhui@mdanderson.org for enrollment information.
Where is the NCT07009886 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07009886 clinical trial?
NCT07009886 is sponsored by M.D. Anderson Cancer Center. The principal investigator is David Hui, MD at M.D. Anderson Cancer Center. The trial plans to enroll 155 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.